A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

NCT06228417 | Completed

• 1 other identifier: 2017_04617
• Study Type: observational
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

A development and pilot test of an app targeting persons with hypertension. Content in the app was based on persons with hypertensions experiences and a literature review. The participants experience of using the app as well as testing a instrument for medication adherence.

Conditions

Hypertension

Keywords

artificial intelligence; focus group; adherence, medication; pilot study

Outcome Measures

Primary Outcomes (2)

• Medication adherence

  Medication adherence measured by the participants self-reported intake of daily medication in the app. The usage is described in frequencies and response time.

  two weeks

• Adherence hypertension medication

  Medication score through the Maastricht Utrecht Adherence in Hypertension (MUAH-16) questionnaire. The questionnaire consists of four subscales: two of them measures positive and two others measures negative aspects of attitudes to medication adherence and health problem. Min value for each subscale are 4 and maximum 28. Higher value indicate better outcome

  two weeks

Interventions

Adaptive digital intervention OTHER

Participants received reminder for medication intake on daily basis. Also, short message regarding hypertension, medication and lifestyle changes

Eligibility Criteria

• Age: 40 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants with hypertension, more than one year, were enrolled. From primary care.

You may qualify if:

• years of age,
• have hypertension (i.e., ICD 10 codes I10-I15 in the person's medical history) for ≥1 year
• have been prescribed medications to treat said hypertension
• speak and understand Swedish
• have a smartphone

You may not qualify if:

• having received medication with unit-dose packages (Apodos)
• previous stroke
• previous myocardial infarction
• psychological disorder or cognitive impairment (i.e. ICD 10 codes F01-F99)
• pregnancy-induced hypertension´
• insulin treatment
• kidney disease, defined as glomerulus filtration rate (GFR) \<60 ml/min.

Sponsors & Collaborators

• Halmstad University: lead
• Vinnova: collaborator

Study Sites (1)

Halmstad University

Halmstad, Sweden

Location

MeSH Terms

Conditions

Hypertension; Medication Adherence

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Slawomir Nowaczyk, Professor

  Halmstad University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: December 27, 2023
• First Posted: January 29, 2024
• Study Start: February 23, 2020
• Primary Completion: February 27, 2021
• Study Completion: March 1, 2021
• Last Updated: March 19, 2024

Record last verified: 2024-03

Locations

SE (1)